ID

22307

Descripción

ALTROPANE® SPECT Imaging in Patients With Parkinson Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00397228

Link

https://clinicaltrials.gov/show/NCT00397228

Palabras clave

Versiones (1)
  1. 29/5/17 29/5/17 -
Subido en

29 de mayo de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Parkinson Disease NCT00397228

Inglés

Eligibility Parkinson Disease NCT00397228

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
the participant is 30 years or older at time of pd diagnosis.
Descripción

Age | Parkinson Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0030567
written informed consent is obtained.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
participants have a clinical diagnosis of idiopathic parkinson's disease of < 7 years.
Descripción

Parkinson Disease disease length

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030567
UMLS CUI [1,2]
C0872146
hoehn and yahr stages i-iii.
Descripción

Hoehn and Yahr Stage

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3639483
negative drug screen
Descripción

Drug screen negative

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0919819
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
the participant has atypical or drug-induced parkinson's disease.
Descripción

Atypical Parkinson Disease | Parkinson Disease Drug-induced

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1868596
UMLS CUI [2,1]
C0030567
UMLS CUI [2,2]
C0458082
the participant has dementia.
Descripción

Dementia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0497327
the participant has a clinically significant clinical laboratory value and/or clinically significant unstable medical or psychiatric illness.
Descripción

Laboratory Results Clinical Significance | Illness Unstable | Mental disorders Unstable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1254595
UMLS CUI [1,2]
C2826293
UMLS CUI [2,1]
C0221423
UMLS CUI [2,2]
C0443343
UMLS CUI [3,1]
C0004936
UMLS CUI [3,2]
C0443343
treatment within the six months prior to screening with bupropion, methylphenidate, reserpine, alpha methyldopa, or amphetamine.
Descripción

Bupropion | Methylphenidate | Reserpine | Methyldopa | Amphetamines

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0085208
UMLS CUI [2]
C0025810
UMLS CUI [3]
C0035179
UMLS CUI [4]
C0025741
UMLS CUI [5]
C0002667
the participant has a history of alcohol, narcotic, or any other drug abuse within the past 2 years.
Descripción

Substance Use Disorders | Narcotic Abuse

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038586
UMLS CUI [2]
C0524661
the participant has received an investigational drug within 60 days of screening visit.
Descripción

Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013230
pregnancy
Descripción

Pregnancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
Volver a la parte superior de la página

Similar models

Eligibility Parkinson Disease NCT00397228

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age | Parkinson Disease
Item
the participant is 30 years or older at time of pd diagnosis.
boolean
C0001779 (UMLS CUI [1])
C0030567 (UMLS CUI [2])
Informed Consent
Item
written informed consent is obtained.
boolean
C0021430 (UMLS CUI [1])
Parkinson Disease disease length
Item
participants have a clinical diagnosis of idiopathic parkinson's disease of < 7 years.
boolean
C0030567 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Hoehn and Yahr Stage
Item
hoehn and yahr stages i-iii.
boolean
C3639483 (UMLS CUI [1])
Drug screen negative
Item
negative drug screen
boolean
C0919819 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Atypical Parkinson Disease | Parkinson Disease Drug-induced
Item
the participant has atypical or drug-induced parkinson's disease.
boolean
C1868596 (UMLS CUI [1])
C0030567 (UMLS CUI [2,1])
C0458082 (UMLS CUI [2,2])
Dementia
Item
the participant has dementia.
boolean
C0497327 (UMLS CUI [1])
Laboratory Results Clinical Significance | Illness Unstable | Mental disorders Unstable
Item
the participant has a clinically significant clinical laboratory value and/or clinically significant unstable medical or psychiatric illness.
boolean
C1254595 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C0221423 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0004936 (UMLS CUI [3,1])
C0443343 (UMLS CUI [3,2])
Bupropion | Methylphenidate | Reserpine | Methyldopa | Amphetamines
Item
treatment within the six months prior to screening with bupropion, methylphenidate, reserpine, alpha methyldopa, or amphetamine.
boolean
C0085208 (UMLS CUI [1])
C0025810 (UMLS CUI [2])
C0035179 (UMLS CUI [3])
C0025741 (UMLS CUI [4])
C0002667 (UMLS CUI [5])
Substance Use Disorders | Narcotic Abuse
Item
the participant has a history of alcohol, narcotic, or any other drug abuse within the past 2 years.
boolean
C0038586 (UMLS CUI [1])
C0524661 (UMLS CUI [2])
Investigational New Drugs
Item
the participant has received an investigational drug within 60 days of screening visit.
boolean
C0013230 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial